| 0 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
84 |
0.1257 |
| 1 |
SERONEGATIVE ARTHRITIS |
141 |
0.1230 |
| 2 |
LUPUS VULGARIS |
137 |
0.1087 |
| 3 |
RETINITIS |
133 |
0.0769 |
| 4 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
120 |
0.0579 |
| 5 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
115 |
0.0574 |
| 6 |
SPINAL FUSION FRACTURE |
1 |
0.0556 |
| 7 |
DISLOCATION OF VERTEBRA |
118 |
0.0517 |
| 8 |
SWOLLEN JOINT COUNT INCREASED |
130 |
0.0407 |
| 9 |
RHEUMATIC FEVER |
131 |
0.0294 |
| 10 |
BONE EROSION |
95 |
0.0268 |
| 11 |
RHEUMATOID FACTOR POSITIVE |
133 |
0.0230 |
| 12 |
SWOLLEN JOINT COUNT |
5 |
0.0200 |
| 13 |
WOUND INFECTION |
215 |
0.0196 |
| 14 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
11 |
0.0196 |
| 15 |
JOINT DISLOCATION |
203 |
0.0192 |
| 16 |
HYPERCHOLESTEROLAEMIA |
168 |
0.0174 |
| 17 |
SPONDYLITIS |
63 |
0.0173 |
| 18 |
HYPOCHOLESTEROLAEMIA |
6 |
0.0170 |
| 19 |
WALKING AID USER |
112 |
0.0170 |
| 20 |
MUSCLE INJURY |
140 |
0.0169 |
| 21 |
JOINT RANGE OF MOTION DECREASED |
204 |
0.0152 |
| 22 |
SPINAL FUSION SURGERY |
61 |
0.0150 |
| 23 |
LOW DENSITY LIPOPROTEIN |
1 |
0.0147 |
| 24 |
LUPUS-LIKE SYNDROME |
133 |
0.0147 |
| 25 |
DUODENAL ULCER PERFORATION |
108 |
0.0145 |
| 26 |
PEMPHIGUS |
180 |
0.0144 |
| 27 |
ACQUIRED PORPHYRIA |
1 |
0.0141 |
| 28 |
HELICOBACTER INFECTION |
143 |
0.0139 |
| 29 |
BREAST CANCER STAGE III |
88 |
0.0136 |
| 30 |
GRIP STRENGTH DECREASED |
116 |
0.0132 |
| 31 |
GRIP STRENGTH |
3 |
0.0131 |
| 32 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
91 |
0.0127 |
| 33 |
TENDER JOINT COUNT |
1 |
0.0119 |
| 34 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
127 |
0.0115 |
| 35 |
FOLLICULITIS |
116 |
0.0111 |
| 36 |
EXOSTOSIS |
100 |
0.0109 |
| 37 |
PERICARDITIS |
182 |
0.0108 |
| 38 |
C-REACTIVE PROTEIN |
10 |
0.0108 |
| 39 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
69 |
0.0106 |
| 40 |
ANTIPHOSPHOLIPID ANTIBODIES |
2 |
0.0103 |
| 41 |
AUTOIMMUNE DISORDER |
100 |
0.0102 |
| 42 |
SCIATICA |
161 |
0.0101 |
| 43 |
PRESCRIBED UNDERDOSE |
201 |
0.0101 |
| 44 |
IRRITABLE BOWEL SYNDROME |
210 |
0.0098 |
| 45 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
1 |
0.0095 |
| 46 |
FOOT DEFORMITY |
104 |
0.0094 |
| 47 |
HIP ARTHROPLASTY |
141 |
0.0092 |
| 48 |
HAND DEFORMITY |
119 |
0.0091 |
| 49 |
GLUTAMATE DEHYDROGENASE INCREASED |
1 |
0.0090 |
| 50 |
X-RAY ABNORMAL |
15 |
0.0084 |
| 51 |
PORPHYRIA ACUTE |
12 |
0.0084 |
| 52 |
SYNOVITIS |
148 |
0.0082 |
| 53 |
JOINT STIFFNESS |
205 |
0.0078 |
| 54 |
PRESCRIBED OVERDOSE |
151 |
0.0078 |
| 55 |
WOUND |
211 |
0.0075 |
| 56 |
DRUG TOLERANCE DECREASED |
21 |
0.0075 |
| 57 |
OVERLAP SYNDROME |
5 |
0.0071 |
| 58 |
PULMONARY FIBROSIS |
137 |
0.0071 |
| 59 |
TYPE 2 DIABETES MELLITUS |
235 |
0.0070 |
| 60 |
LOWER LIMB FRACTURE |
132 |
0.0069 |
| 61 |
FACET JOINT SYNDROME |
22 |
0.0068 |
| 62 |
HEPATIC ENZYME |
1 |
0.0067 |
| 63 |
FIBROMYALGIA |
155 |
0.0064 |
| 64 |
LIVER FUNCTION TEST INCREASED |
134 |
0.0062 |
| 65 |
LIVER INJURY |
152 |
0.0062 |
| 66 |
VARICELLA VIRUS TEST POSITIVE |
1 |
0.0059 |
| 67 |
HEPATIC CIRRHOSIS |
108 |
0.0057 |
| 68 |
KNEE ARTHROPLASTY |
121 |
0.0057 |
| 69 |
PERIPHERAL VENOUS DISEASE |
23 |
0.0056 |
| 70 |
GLOSSODYNIA |
122 |
0.0054 |
| 71 |
IMPAIRED HEALING |
171 |
0.0052 |
| 72 |
OSTEOARTHRITIS |
199 |
0.0047 |
| 73 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
158 |
0.0044 |
| 74 |
UPPER RESPIRATORY TRACT INFECTION |
200 |
0.0043 |
| 75 |
DISABILITY |
84 |
0.0042 |
| 76 |
PSORIATIC ARTHROPATHY |
161 |
0.0040 |
| 77 |
TRI-IODOTHYRONINE FREE DECREASED |
1 |
0.0039 |
| 78 |
OSTEOPOROSIS |
161 |
0.0039 |
| 79 |
JOINT DESTRUCTION |
6 |
0.0039 |
| 80 |
ROAD TRAFFIC ACCIDENT |
157 |
0.0037 |
| 81 |
EAR INFECTION |
97 |
0.0036 |
| 82 |
INSPIRATORY CAPACITY DECREASED |
1 |
0.0036 |
| 83 |
GAIT INABILITY |
120 |
0.0036 |
| 84 |
ONYCHOMADESIS |
15 |
0.0036 |
| 85 |
DAIRY INTOLERANCE |
1 |
0.0036 |
| 86 |
LIP DRY |
32 |
0.0035 |
| 87 |
WHEEZING |
207 |
0.0035 |
| 88 |
DELIRIUM |
119 |
0.0034 |
| 89 |
C-REACTIVE PROTEIN INCREASED |
120 |
0.0033 |
| 90 |
DRUG-INDUCED LIVER INJURY |
102 |
0.0032 |
| 91 |
OEDEMA |
174 |
0.0032 |
| 92 |
BLEPHAROSPASM |
20 |
0.0032 |
| 93 |
UTERINE NEOPLASM |
1 |
0.0030 |
| 94 |
INFUSION RELATED REACTION |
196 |
0.0030 |
| 95 |
POLYMERASE CHAIN REACTION POSITIVE |
1 |
0.0029 |
| 96 |
C-REACTIVE PROTEIN ABNORMAL |
18 |
0.0028 |
| 97 |
ANKLE ARTHROPLASTY |
1 |
0.0028 |
| 98 |
BLOOD CHOLESTEROL INCREASED |
128 |
0.0027 |
| 99 |
INFUSION SITE REACTION |
8 |
0.0027 |
| 100 |
TOXIC EPIDERMAL NECROLYSIS |
40 |
0.0026 |
| 101 |
MOBILITY DECREASED |
183 |
0.0025 |
| 102 |
LIVE BIRTH |
20 |
0.0024 |
| 103 |
INJURY |
167 |
0.0024 |
| 104 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
40 |
0.0024 |
| 105 |
ONYCHOMYCOSIS |
10 |
0.0023 |
| 106 |
BURSITIS |
26 |
0.0021 |
| 107 |
NAIL DISORDER |
18 |
0.0021 |
| 108 |
PUSTULAR PSORIASIS |
7 |
0.0020 |
| 109 |
ARTHROPATHY |
110 |
0.0020 |
| 110 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
94 |
0.0020 |
| 111 |
BREAST CANCER STAGE I |
18 |
0.0019 |
| 112 |
HEPATIC ENZYME INCREASED |
132 |
0.0019 |
| 113 |
STOMATITIS |
115 |
0.0019 |
| 114 |
BREAST CANCER STAGE II |
15 |
0.0018 |
| 115 |
MUSCULOSKELETAL STIFFNESS |
156 |
0.0018 |
| 116 |
THYROXINE FREE DECREASED |
1 |
0.0018 |
| 117 |
BLISTER |
98 |
0.0017 |
| 118 |
AMNESIA |
111 |
0.0017 |
| 119 |
VISUAL IMPAIRMENT |
201 |
0.0016 |
| 120 |
DERMATOSIS |
1 |
0.0016 |
| 121 |
DISCOMFORT |
97 |
0.0016 |
| 122 |
SINUSITIS |
162 |
0.0016 |
| 123 |
SUSPECTED OFF LABEL USE |
7 |
0.0015 |
| 124 |
ULCER HAEMORRHAGE |
10 |
0.0015 |
| 125 |
TACHYCARDIA |
129 |
0.0015 |
| 126 |
MYOSITIS |
13 |
0.0014 |
| 127 |
CONTRAINDICATED PRODUCT ADMINISTERED |
42 |
0.0014 |
| 128 |
RHEUMATOID ARTHRITIS |
154 |
0.0014 |
| 129 |
URTICARIA |
224 |
0.0013 |
| 130 |
HYPOAESTHESIA |
200 |
0.0013 |
| 131 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
5 |
0.0013 |
| 132 |
MUSCULAR WEAKNESS |
150 |
0.0013 |
| 133 |
OEDEMA PERIPHERAL |
158 |
0.0013 |
| 134 |
SWELLING |
120 |
0.0013 |
| 135 |
BRONCHITIS |
94 |
0.0013 |
| 136 |
GENERAL PHYSICAL HEALTH DETERIORATION |
145 |
0.0013 |
| 137 |
CONTUSION |
120 |
0.0012 |
| 138 |
RASH VESICULAR |
6 |
0.0012 |
| 139 |
INFECTION |
178 |
0.0012 |
| 140 |
DYSBIOSIS |
1 |
0.0012 |
| 141 |
LEUKOCYTURIA |
1 |
0.0012 |
| 142 |
ARTHRITIS |
95 |
0.0012 |
| 143 |
PRODUCT LABEL CONFUSION |
7 |
0.0012 |
| 144 |
BACK INJURY |
13 |
0.0012 |
| 145 |
JOINT SWELLING |
141 |
0.0012 |
| 146 |
PERIPHERAL SWELLING |
172 |
0.0011 |
| 147 |
SLEEP DISORDER |
77 |
0.0011 |
| 148 |
WEIGHT INCREASED |
241 |
0.0011 |
| 149 |
GENERAL SYMPTOM |
8 |
0.0011 |
| 150 |
OBESITY |
17 |
0.0011 |
| 151 |
DYSPEPSIA |
103 |
0.0010 |
| 152 |
RED BLOOD CELLS URINE POSITIVE |
1 |
0.0010 |
| 153 |
ASTHMA |
116 |
0.0010 |
| 154 |
NIGHT SWEATS |
33 |
0.0010 |
| 155 |
MEMORY IMPAIRMENT |
139 |
0.0010 |
| 156 |
PSORIASIS |
132 |
0.0010 |
| 157 |
NASOPHARYNGITIS |
186 |
0.0010 |
| 158 |
HYPERTENSION |
213 |
0.0010 |
| 159 |
HYPERSENSITIVITY |
184 |
0.0010 |
| 160 |
EYE INJURY |
3 |
0.0010 |
| 161 |
HYPOCHROMIC ANAEMIA |
1 |
0.0010 |
| 162 |
BONE MARROW OEDEMA |
1 |
0.0010 |
| 163 |
POLYARTHRITIS |
5 |
0.0009 |
| 164 |
TOXOPLASMOSIS |
1 |
0.0009 |
| 165 |
COELIAC DISEASE |
9 |
0.0009 |
| 166 |
PREGNANCY AFTER POST COITAL CONTRACEPTION |
2 |
0.0009 |
| 167 |
ABDOMINAL DISCOMFORT |
147 |
0.0009 |
| 168 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
15 |
0.0009 |
| 169 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
2 |
0.0009 |
| 170 |
FOLATE DEFICIENCY |
1 |
0.0009 |
| 171 |
BONE MARROW TOXICITY |
1 |
0.0008 |
| 172 |
TASTE DISORDER |
17 |
0.0008 |
| 173 |
INTENTIONAL PRODUCT USE ISSUE |
71 |
0.0008 |
| 174 |
XEROSIS |
1 |
0.0008 |
| 175 |
DRUG TOLERANCE |
4 |
0.0008 |
| 176 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 177 |
HEPATOSPLENOMEGALY |
2 |
0.0008 |
| 178 |
EAR PAIN |
15 |
0.0008 |
| 179 |
DRUG INTOLERANCE |
74 |
0.0008 |
| 180 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
2 |
0.0008 |
| 181 |
PROTEIN TOTAL INCREASED |
2 |
0.0008 |
| 182 |
LOWER RESPIRATORY TRACT INFECTION |
33 |
0.0007 |
| 183 |
HYPERTRANSAMINASAEMIA |
5 |
0.0007 |
| 184 |
ALOPECIA |
141 |
0.0007 |
| 185 |
RENAL TUBULAR DISORDER |
2 |
0.0007 |
| 186 |
WEIGHT DECREASED |
198 |
0.0007 |
| 187 |
FEBRILE BONE MARROW APLASIA |
3 |
0.0007 |
| 188 |
POST HERPETIC NEURALGIA |
1 |
0.0007 |
| 189 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
30 |
0.0007 |
| 190 |
MYELOFIBROSIS |
2 |
0.0007 |
| 191 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 192 |
LUNG DISORDER |
32 |
0.0007 |
| 193 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 194 |
CONFUSIONAL STATE |
102 |
0.0006 |
| 195 |
CHEST PAIN |
116 |
0.0006 |
| 196 |
EPILEPSY |
19 |
0.0006 |
| 197 |
FINGER DEFORMITY |
3 |
0.0006 |
| 198 |
GAIT DISTURBANCE |
117 |
0.0006 |
| 199 |
SPINAL CORD DISORDER |
1 |
0.0006 |
| 200 |
IMMUNODEFICIENCY |
9 |
0.0006 |
| 201 |
PAIN IN EXTREMITY |
173 |
0.0006 |
| 202 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
2 |
0.0006 |
| 203 |
DECREASED APPETITE |
133 |
0.0006 |
| 204 |
TYPE I HYPERSENSITIVITY |
2 |
0.0006 |
| 205 |
JOINT ARTHROPLASTY |
1 |
0.0006 |
| 206 |
UTERINE POLYP |
1 |
0.0006 |
| 207 |
OPHTHALMIC HERPES ZOSTER |
1 |
0.0006 |
| 208 |
BACK DISORDER |
9 |
0.0006 |
| 209 |
MATERNAL EXPOSURE DURING PREGNANCY |
49 |
0.0005 |
| 210 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 211 |
ADVERSE EVENT |
50 |
0.0005 |
| 212 |
AUTOIMMUNE THYROIDITIS |
2 |
0.0005 |
| 213 |
SPINAL DISORDER |
5 |
0.0005 |
| 214 |
PNEUMONIA |
168 |
0.0005 |
| 215 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 216 |
ADRENAL INSUFFICIENCY |
6 |
0.0005 |
| 217 |
PYREXIA |
170 |
0.0005 |
| 218 |
ADVERSE DRUG REACTION |
43 |
0.0005 |
| 219 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 220 |
VOMITING |
222 |
0.0005 |
| 221 |
RENAL NEOPLASM |
1 |
0.0005 |
| 222 |
CONDITION AGGRAVATED |
143 |
0.0005 |
| 223 |
INFLAMMATION |
24 |
0.0005 |
| 224 |
DEPRESSION |
105 |
0.0005 |
| 225 |
RENAL TUBULAR ACIDOSIS |
1 |
0.0005 |
| 226 |
TREATMENT FAILURE |
37 |
0.0004 |
| 227 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 228 |
PRURITUS |
169 |
0.0004 |
| 229 |
EYELID DISORDER |
1 |
0.0004 |
| 230 |
UROSEPSIS |
4 |
0.0004 |
| 231 |
MUSCULOSKELETAL PAIN |
22 |
0.0004 |
| 232 |
ILL-DEFINED DISORDER |
25 |
0.0004 |
| 233 |
LIVER DISORDER |
18 |
0.0004 |
| 234 |
DENTAL OPERATION |
1 |
0.0004 |
| 235 |
RESPIRATORY DISORDER |
12 |
0.0004 |
| 236 |
DERMATITIS EXFOLIATIVE |
2 |
0.0004 |
| 237 |
PREGNANCY |
8 |
0.0004 |
| 238 |
THERAPY NON-RESPONDER |
17 |
0.0004 |
| 239 |
FREQUENT BOWEL MOVEMENTS |
10 |
0.0004 |
| 240 |
NORMAL NEWBORN |
2 |
0.0004 |
| 241 |
RASH |
158 |
0.0004 |
| 242 |
ANXIETY |
102 |
0.0004 |
| 243 |
GRANULOCYTOPENIA |
2 |
0.0004 |
| 244 |
MIGRAINE |
32 |
0.0003 |
| 245 |
HEPATITIS CHOLESTATIC |
2 |
0.0003 |
| 246 |
UNDERDOSE |
24 |
0.0003 |
| 247 |
MUSCLE SPASTICITY |
4 |
0.0003 |
| 248 |
WHITE BLOOD CELL COUNT INCREASED |
12 |
0.0003 |
| 249 |
ARTHRALGIA |
124 |
0.0003 |
| 250 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 251 |
COLITIS ULCERATIVE |
13 |
0.0003 |
| 252 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 253 |
WEIGHT FLUCTUATION |
3 |
0.0003 |
| 254 |
DRY MOUTH |
23 |
0.0003 |
| 255 |
PAIN |
174 |
0.0003 |
| 256 |
DIZZINESS |
139 |
0.0003 |
| 257 |
HEPATITIS |
7 |
0.0003 |
| 258 |
EXPOSURE DURING PREGNANCY |
17 |
0.0003 |
| 259 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 260 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 261 |
MEDICATION ERROR |
14 |
0.0003 |
| 262 |
VITAMIN B12 DEFICIENCY |
1 |
0.0002 |
| 263 |
PARAESTHESIA |
38 |
0.0002 |
| 264 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 265 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 266 |
GASTROOESOPHAGEAL REFLUX DISEASE |
19 |
0.0002 |
| 267 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 268 |
PULMONARY TUBERCULOSIS |
1 |
0.0002 |
| 269 |
NECK PAIN |
13 |
0.0002 |
| 270 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 271 |
NODULE |
3 |
0.0002 |
| 272 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 273 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 274 |
PANCREATITIS |
12 |
0.0002 |
| 275 |
WHEELCHAIR USER |
1 |
0.0002 |
| 276 |
NAUSEA |
177 |
0.0002 |
| 277 |
GASTROINTESTINAL DISORDER |
20 |
0.0002 |
| 278 |
HEADACHE |
139 |
0.0002 |
| 279 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 280 |
HYPOKALAEMIA |
10 |
0.0002 |
| 281 |
INSOMNIA |
57 |
0.0002 |
| 282 |
SQUAMOUS CELL CARCINOMA |
2 |
0.0002 |
| 283 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
15 |
0.0002 |
| 284 |
INFLAMMATORY BOWEL DISEASE |
2 |
0.0002 |
| 285 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 286 |
FOOT OPERATION |
1 |
0.0002 |
| 287 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 288 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 289 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 290 |
FLUID RETENTION |
10 |
0.0002 |
| 291 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
| 292 |
FEELING HOT |
12 |
0.0002 |
| 293 |
PRODUCT USE IN UNAPPROVED INDICATION |
48 |
0.0002 |
| 294 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 295 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 296 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
4 |
0.0002 |
| 297 |
DYSPNOEA |
104 |
0.0002 |
| 298 |
FATIGUE |
140 |
0.0002 |
| 299 |
RASH MACULO-PAPULAR |
4 |
0.0002 |
| 300 |
PRODUCT USE ISSUE |
33 |
0.0002 |
| 301 |
DIARRHOEA |
112 |
0.0002 |
| 302 |
LABORATORY TEST ABNORMAL |
5 |
0.0002 |
| 303 |
GASTROENTERITIS VIRAL |
3 |
0.0002 |
| 304 |
THERAPEUTIC RESPONSE DECREASED |
10 |
0.0002 |
| 305 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 306 |
OFF LABEL USE |
142 |
0.0002 |
| 307 |
HYPOCALCAEMIA |
3 |
0.0002 |
| 308 |
MUSCLE SPASMS |
29 |
0.0002 |
| 309 |
ENTERITIS |
1 |
0.0002 |
| 310 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0002 |
| 311 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 312 |
ADVERSE REACTION |
2 |
0.0002 |
| 313 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 314 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 315 |
CROHN'S DISEASE |
1 |
0.0001 |
| 316 |
HAEMOPTYSIS |
4 |
0.0001 |
| 317 |
LEUKOPENIA |
7 |
0.0001 |
| 318 |
GASTROENTERITIS |
2 |
0.0001 |
| 319 |
PEMPHIGOID |
1 |
0.0001 |
| 320 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 321 |
DIABETES MELLITUS |
10 |
0.0001 |
| 322 |
ABDOMINAL PAIN UPPER |
27 |
0.0001 |
| 323 |
SHOCK |
3 |
0.0001 |
| 324 |
ANKLE FRACTURE |
2 |
0.0001 |
| 325 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 326 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 327 |
SKIN LESION |
3 |
0.0001 |
| 328 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 329 |
ABORTION INDUCED |
1 |
0.0001 |
| 330 |
PROTEINURIA |
2 |
0.0001 |
| 331 |
LETHARGY |
6 |
0.0001 |
| 332 |
PRODUCT QUALITY ISSUE |
14 |
0.0001 |
| 333 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 334 |
EYELID PTOSIS |
1 |
0.0001 |
| 335 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 336 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 337 |
RASH PRURITIC |
5 |
0.0001 |
| 338 |
TREATMENT NONCOMPLIANCE |
5 |
0.0001 |
| 339 |
ASPIRATION |
1 |
0.0001 |
| 340 |
INJECTION SITE REACTION |
6 |
0.0001 |
| 341 |
EYELID OEDEMA |
1 |
0.0001 |
| 342 |
SPINAL PAIN |
1 |
0.0001 |
| 343 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 344 |
MALAISE |
36 |
0.0001 |
| 345 |
CYTOPENIA |
1 |
0.0001 |
| 346 |
ABDOMINAL PAIN |
19 |
0.0001 |
| 347 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 348 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 349 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 350 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 351 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 352 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 353 |
SKIN REACTION |
1 |
0.0001 |
| 354 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 355 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 356 |
ASTHENIA |
26 |
0.0001 |
| 357 |
SEPTIC SHOCK |
3 |
0.0001 |
| 358 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 359 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 360 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 361 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 362 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 363 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 364 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 365 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 366 |
TOOTHACHE |
1 |
0.0001 |
| 367 |
BONE DISORDER |
1 |
0.0001 |
| 368 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 369 |
DRUG INEFFECTIVE |
72 |
0.0001 |
| 370 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 371 |
PANCYTOPENIA |
3 |
0.0001 |
| 372 |
PHOTOPHOBIA |
1 |
0.0001 |
| 373 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 374 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 375 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 376 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 377 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 378 |
MALIGNANT NEOPLASM PROGRESSION |
5 |
0.0000 |
| 379 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 380 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 381 |
HEPATOTOXICITY |
1 |
0.0000 |
| 382 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 383 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 384 |
NEURALGIA |
1 |
0.0000 |
| 385 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 386 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 387 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 388 |
SEDATION |
1 |
0.0000 |
| 389 |
ANHEDONIA |
1 |
0.0000 |
| 390 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 391 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 392 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 393 |
HEPATIC FAILURE |
1 |
0.0000 |
| 394 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 395 |
DEATH |
27 |
0.0000 |
| 396 |
HIP FRACTURE |
1 |
0.0000 |
| 397 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 398 |
LIP SWELLING |
1 |
0.0000 |
| 399 |
EYE PRURITUS |
1 |
0.0000 |
| 400 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 401 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 402 |
HAEMATURIA |
1 |
0.0000 |
| 403 |
NIGHTMARE |
1 |
0.0000 |
| 404 |
OVERDOSE |
6 |
0.0000 |
| 405 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 406 |
DYSARTHRIA |
1 |
0.0000 |
| 407 |
COLITIS |
1 |
0.0000 |
| 408 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 409 |
POLLAKIURIA |
1 |
0.0000 |
| 410 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 411 |
SKIN IRRITATION |
1 |
0.0000 |
| 412 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 413 |
HYPOTENSION |
4 |
0.0000 |
| 414 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 415 |
HOSPITALISATION |
3 |
0.0000 |
| 416 |
ECZEMA |
1 |
0.0000 |
| 417 |
DEPRESSED MOOD |
1 |
0.0000 |
| 418 |
FALL |
6 |
0.0000 |
| 419 |
SEPSIS |
2 |
0.0000 |
| 420 |
FLATULENCE |
1 |
0.0000 |
| 421 |
HERPES ZOSTER |
1 |
0.0000 |
| 422 |
BACK PAIN |
4 |
0.0000 |
| 423 |
BONE PAIN |
1 |
0.0000 |
| 424 |
SURGERY |
1 |
0.0000 |
| 425 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 426 |
HYPERHIDROSIS |
2 |
0.0000 |
| 427 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 428 |
SWELLING FACE |
1 |
0.0000 |
| 429 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 430 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 431 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 432 |
EPISTAXIS |
1 |
0.0000 |
| 433 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 434 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 435 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 436 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 437 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 438 |
MYALGIA |
2 |
0.0000 |
| 439 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 440 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 441 |
BREAST CANCER |
1 |
0.0000 |
| 442 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 443 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 444 |
CHILLS |
1 |
0.0000 |
| 445 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 446 |
RENAL FAILURE |
1 |
0.0000 |
| 447 |
NEUTROPENIA |
1 |
0.0000 |
| 448 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 449 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 450 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 451 |
ANAEMIA |
1 |
0.0000 |
| 452 |
ERYTHEMA |
1 |
0.0000 |
| 453 |
FEELING ABNORMAL |
1 |
0.0000 |